Growth hormone injection for children born small for gestational age
Part of Hormones & metabolism clinical trials.
This study tests a new growth hormone injection (Jinpei) to help children who were born small for gestational age (SGA) and are still short for their age. The treatment may help them grow taller.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Born small for gestational age (birth weight and/or length below the 10th percentile for their gestational age)
- At least 3 years old
- Has not started puberty (prepubertal)
- Height is more than 2 standard deviations below the average for their age and sex
- No prior treatment with growth hormone or similar medications
- Willing and able to comply with study procedures and follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental growth hormone (Inpegsomatropin) to help children born small for gestational age who remain short. If your child meets the specific height, age, and puberty criteria, they may qualify.
This trial studies the long-term safety and effectiveness of Growtropin®-II, a growth hormone–type injection, in children who are short due to certain causes. It may help your child’s growth over time, while also closely tracking side effects.
This trial tests a weekly growth hormone injection called PEG-rhGH to see if it helps short children born small for gestational age grow taller. It may be an option if your child has never taken growth hormone before and meets the height and age requirements.
This study tests if growth hormone can safely help children who are shorter than average for their age and gender. It is for children with certain conditions that cause short stature.
This trial is testing an experimental growth hormone treatment for children who are short for their age but otherwise healthy. Participation may help determine if the treatment can safely improve growth.
This study tests a new once-a-week injection (GenSci134) for children with growth hormone deficiency. It aims to see if it is safe and helps them grow. Your child may be able to join if they have not been treated before and meet the age and height requirements.
Hear when a new Small for Gestational Age trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.